# THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring

> **NCT01970969** · — · COMPLETED · sponsor: **Scripps Translational Science Institute** · enrollment: 928 (actual)

## Conditions studied

- Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01970969
- **Lead sponsor:** Scripps Translational Science Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 928 (ACTUAL)
- **Last updated:** 2018-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01970969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01970969, "THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01970969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*